TherapeuticsMD, Inc. Announces Plans in Hormone Therapy That Concur With the Recent Joint Statement from NAMS, ASRM and The Endocrine Society
7/10/2012 10:35:15 AM
More...
|
Radius Announces Upcoming Scientific Presentations at ENDO 2012, the Endocrine Society's 94th Annual Meeting
6/22/2012 10:55:32 AM
More...
|
Experts Find Continuous Glucose Monitoring Beneficial in Maintaining Target Blood Glucose Levels, Endocrine Society Reveals
10/12/2011 8:00:31 AM
More...
|
Ligand Pharmaceuticals Inc. (LGND) Presents Multi-Dose Phase I Data on Lead SARM Molecule LGD-4033 at the Endocrine Society Annual Meeting
6/6/2011 11:46:37 AM
More...
|
Versartis, Inc. Long-Term Preclinical Safety Data for VRS-317 Presented at Endocrine Society 2011
6/6/2011 9:28:27 AM
More...
|
Corcept Therapeutics Inc. (CORT) Announces Conference Call to Discuss Detailed Findings From Corlux Phase 3 Trial in Cushing's Syndrome at the Endocrine Society's Annual Meeting
6/1/2011 6:33:40 AM
More...
|
Corcept Therapeutics Inc. (CORT) to Present Detailed Findings From CORLUX Phase 3 Trial in Cushing's Syndrome at the Endocrine Society's Annual Meeting, June 4-7
5/19/2011 9:03:23 AM
More...
|
Endocrine Society's Annual Meeting to Feature Data on Endocrine Society's Qnexa
6/17/2010 10:42:38 AM
More...
|
Aegis Therapeutics, LLC's First Orally Bioavailable Anti-Obesity/Diabetes Peptide Drug Candidate to Be Presented at the Aegis Therapeutics, LLC Annual Meeting in San Diego, June 19-22, 2010
5/13/2010 10:28:03 AM
More...
|
Theratechnologies Inc. (TH.TO) Presents Results From a Pharmacokinetic/Phamacodynamic Evaluation of Tesamorelin at the Endocrine Society's Annual Meeting
6/15/2009 11:36:50 AM
More...
|
|